| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3850788 | American Journal of Kidney Diseases | 2009 | 11 Pages |
Abstract
Pentoxifylline may slow the estimated GFR decrease in high-risk patients. This may be independent of its antiproteinuric properties and warrants further investigation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Robert M. MD, Matthew C. MD, Alice L. MD, Stephen W. MD, Howard M. MD, Christina M. MD,